Table of Contents
3 - 6 ਮਹੀਨਿਆਂ ਲਈ ਸਰਵੋਤਮ ਮਿਉਚੁਅਲ ਫੰਡ
3 ਤੋਂ 6 ਮਹੀਨਿਆਂ ਦੀ ਛੋਟੀ ਮਿਆਦ ਲਈ, ਤੁਸੀਂ ਜਾਂ ਤਾਂ ਆਪਣੇ ਪੈਸੇ ਪਾਰਕ ਕਰ ਸਕਦੇ ਹੋਤਰਲ ਮਿਉਚੁਅਲ ਫੰਡ ਜਾਂ ਅਤਿ ਥੋੜ੍ਹੇ ਸਮੇਂ ਲਈਕਰਜ਼ਾ ਮਿਉਚੁਅਲ ਫੰਡ. ਤਰਲਮਿਉਚੁਅਲ ਫੰਡ ਆਮ ਤੌਰ 'ਤੇ ਸਰਕਾਰੀ ਪ੍ਰਤੀਭੂਤੀਆਂ ਵਿੱਚ ਨਿਵੇਸ਼ ਕਰਦੇ ਹਨ ਅਤੇ 3 ਮਹੀਨਿਆਂ ਤੱਕ ਦੀ ਮਿਆਦ ਦੇ ਜਮ੍ਹਾਂ ਦੇ ਸਰਟੀਫਿਕੇਟ.
ਹਾਲਾਂਕਿ ਜੇਕਰ ਕੋਈ ਉੱਚ ਰਿਟਰਨ ਲਈ ਜੋਖਮ ਲੈਣ ਲਈ ਉਤਸੁਕ ਹੈ ਤਾਂ ਹੇਠਾਂ ਦਿੱਤੇ ਕੁਝ ਵਿਕਲਪਾਂ ਨੂੰ ਦੇਖ ਸਕਦੇ ਹੋ
ਚੋਟੀ ਦੇ 5 ਹੌਟ ਮਿਉਚੁਅਲ ਫੰਡ 3 ਮਹੀਨੇ
ਦੀ ਸੂਚੀ ਹੇਠਾਂ ਦਿੱਤੀ ਗਈ ਹੈਵਧੀਆ ਮਿਉਚੁਅਲ ਫੰਡ ਕੁੱਲ ਸੰਪਤੀਆਂ ਹੋਣ100 ਕਰੋੜ ਅਤੇ ਪਿਛਲੇ 3 ਮਹੀਨਿਆਂ ਵਿੱਚ ਸਭ ਤੋਂ ਵਧੀਆ ਰਿਟਰਨ ਦਿੱਤਾ ਹੈ।
(Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. Nippon India Pharma Fund is a Equity - Sectoral fund was launched on 5 Jun 04. It is a fund with High risk and has given a Below is the key information for Nippon India Pharma Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in Information Technology Sector in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA Digital India Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA Digital India Fund Returns up to 1 year are on 1. UTI Healthcare Fund
CAGR/Annualized return of 15.5% since its launch. Ranked 40 in Sectoral category. Return for 2023 was 38.2% , 2022 was -12.3% and 2021 was 19.1% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (11 Oct 24) ₹289.796 ↑ 0.83 (0.29 %) Net Assets (Cr) ₹1,168 on 31 Aug 24 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 2.49 Information Ratio -0.01 Alpha Ratio 1.29 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 19 ₹10,000 30 Sep 20 ₹16,648 30 Sep 21 ₹21,858 30 Sep 22 ₹19,247 30 Sep 23 ₹23,816 30 Sep 24 ₹37,158 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Oct 24 Duration Returns 1 Month 0.8% 3 Month 17.5% 6 Month 28.7% 1 Year 57.7% 3 Year 19.2% 5 Year 30.6% 10 Year 15 Year Since launch 15.5% Historical performance (Yearly) on absolute basis
Year Returns 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% 2014 43.7% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 2.34 Yr. Data below for UTI Healthcare Fund as on 31 Aug 24
Equity Sector Allocation
Sector Value Health Care 95.09% Financial Services 1.33% Basic Materials 1.06% Asset Allocation
Asset Class Value Cash 2.41% Equity 97.48% Debt 0.11% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA11% ₹134 Cr 735,274 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000877% ₹78 Cr 469,180 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | AJANTPHARM6% ₹65 Cr 200,000
↓ -35,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY5% ₹61 Cr 87,100 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP4% ₹45 Cr 64,796 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | GLENMARK4% ₹43 Cr 250,331 Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | ERIS4% ₹41 Cr 297,746 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMA3% ₹39 Cr 250,000
↓ -5,167 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5001263% ₹39 Cr 74,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5328433% ₹35 Cr 634,445 2. TATA India Pharma & Healthcare Fund
CAGR/Annualized return of 13.9% since its launch. Return for 2023 was 36.6% , 2022 was -8% and 2021 was 19.1% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (11 Oct 24) ₹31.3492 ↑ 0.25 (0.80 %) Net Assets (Cr) ₹1,183 on 31 Aug 24 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 2.52 Information Ratio 0.22 Alpha Ratio 2.69 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 19 ₹10,000 30 Sep 20 ₹15,426 30 Sep 21 ₹20,236 30 Sep 22 ₹18,886 30 Sep 23 ₹23,040 30 Sep 24 ₹35,336 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Oct 24 Duration Returns 1 Month 0.9% 3 Month 14.7% 6 Month 23.3% 1 Year 56.2% 3 Year 20.6% 5 Year 29.4% 10 Year 15 Year Since launch 13.9% Historical performance (Yearly) on absolute basis
Year Returns 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 2014 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Meeta Shetty 9 Mar 21 3.48 Yr. Data below for TATA India Pharma & Healthcare Fund as on 31 Aug 24
Equity Sector Allocation
Sector Value Health Care 90.64% Basic Materials 1.92% Asset Allocation
Asset Class Value Cash 6.87% Equity 93.13% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA12% ₹147 Cr 804,300 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA10% ₹116 Cr 741,000 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 5002578% ₹92 Cr 410,240
↓ -100,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | DRREDDY7% ₹86 Cr 122,911
↑ 15,268 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 5000877% ₹81 Cr 490,000
↑ 75,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB5% ₹53 Cr 104,965 Zydus Lifesciences Ltd (Healthcare)
Equity, Since 31 Dec 22 | 5323214% ₹53 Cr 471,287 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 5328434% ₹47 Cr 855,100 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | 5395234% ₹46 Cr 75,249 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP3% ₹41 Cr 58,903 3. Nippon India Pharma Fund
CAGR/Annualized return of 21.5% since its launch. Ranked 35 in Sectoral category. Return for 2023 was 39.2% , 2022 was -9.9% and 2021 was 23.9% . Nippon India Pharma Fund
Growth Launch Date 5 Jun 04 NAV (11 Oct 24) ₹527.065 ↑ 4.52 (0.87 %) Net Assets (Cr) ₹8,648 on 31 Aug 24 Category Equity - Sectoral AMC Nippon Life Asset Management Ltd. Rating ☆☆ Risk High Expense Ratio 1.88 Sharpe Ratio 2.45 Information Ratio -0.08 Alpha Ratio 1.11 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 19 ₹10,000 30 Sep 20 ₹16,072 30 Sep 21 ₹21,926 30 Sep 22 ₹20,112 30 Sep 23 ₹25,121 30 Sep 24 ₹37,270 Returns for Nippon India Pharma Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Oct 24 Duration Returns 1 Month 0.9% 3 Month 14.2% 6 Month 22.2% 1 Year 51.1% 3 Year 19.4% 5 Year 30.6% 10 Year 15 Year Since launch 21.5% Historical performance (Yearly) on absolute basis
Year Returns 2023 39.2% 2022 -9.9% 2021 23.9% 2020 66.4% 2019 1.7% 2018 3.6% 2017 7.6% 2016 -10.6% 2015 19.4% 2014 49.5% Fund Manager information for Nippon India Pharma Fund
Name Since Tenure Sailesh Raj Bhan 1 Apr 05 19.43 Yr. Kinjal Desai 25 May 18 6.27 Yr. Data below for Nippon India Pharma Fund as on 31 Aug 24
Equity Sector Allocation
Sector Value Health Care 96.47% Asset Allocation
Asset Class Value Cash 2.6% Equity 97.4% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMA14% ₹1,194 Cr 6,556,349 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | 5002578% ₹718 Cr 3,203,676 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB8% ₹688 Cr 1,350,808 Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | 5000876% ₹513 Cr 3,100,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | DRREDDY6% ₹492 Cr 700,030 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Sep 20 | APOLLOHOSP5% ₹449 Cr 648,795 Ajanta Pharma Ltd (Healthcare)
Equity, Since 30 Apr 22 | AJANTPHARM4% ₹311 Cr 959,323 Vijaya Diagnostic Centre Ltd (Healthcare)
Equity, Since 30 Sep 21 | 5433503% ₹276 Cr 3,027,149 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND3% ₹276 Cr 1,500,000 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Dec 15 | AUROPHARMA3% ₹267 Cr 1,702,630
↓ -98,170 4. SBI Healthcare Opportunities Fund
CAGR/Annualized return of 16.1% since its launch. Ranked 34 in Sectoral category. Return for 2023 was 38.2% , 2022 was -6% and 2021 was 20.1% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (10 Oct 24) ₹419.615 ↓ -4.62 (-1.09 %) Net Assets (Cr) ₹3,203 on 31 Aug 24 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 2.32 Information Ratio 0.51 Alpha Ratio -0.99 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 19 ₹10,000 30 Sep 20 ₹16,390 30 Sep 21 ₹21,533 30 Sep 22 ₹20,079 30 Sep 23 ₹25,897 30 Sep 24 ₹38,702 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Oct 24 Duration Returns 1 Month 0.5% 3 Month 13.6% 6 Month 20% 1 Year 51.9% 3 Year 21.8% 5 Year 31.5% 10 Year 15 Year Since launch 16.1% Historical performance (Yearly) on absolute basis
Year Returns 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% 2014 56.8% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 13.26 Yr. Pradeep Kesavan 31 Dec 23 0.67 Yr. Data below for SBI Healthcare Opportunities Fund as on 31 Aug 24
Equity Sector Allocation
Sector Value Health Care 90.07% Basic Materials 6.15% Asset Allocation
Asset Class Value Cash 3.76% Equity 96.24% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA12% ₹383 Cr 2,100,000
↓ -100,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB6% ₹183 Cr 360,000
↓ -40,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002576% ₹179 Cr 800,000
↑ 132,234 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | 5432205% ₹174 Cr 2,021,773
↓ -78,227 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000875% ₹165 Cr 1,000,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY5% ₹164 Cr 300,000 Poly Medicure Ltd (Healthcare)
Equity, Since 31 Aug 24 | 5317685% ₹149 Cr 638,297
↑ 638,297 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5433084% ₹127 Cr 500,000 Aether Industries Ltd (Basic Materials)
Equity, Since 31 May 22 | 5435344% ₹125 Cr 1,400,000 Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5439804% ₹120 Cr 900,000
↑ 7,119 5. TATA Digital India Fund
CAGR/Annualized return of 20.8% since its launch. Return for 2023 was 31.9% , 2022 was -23.3% and 2021 was 74.4% . TATA Digital India Fund
Growth Launch Date 28 Dec 15 NAV (11 Oct 24) ₹52.6998 ↑ 0.57 (1.10 %) Net Assets (Cr) ₹12,041 on 31 Aug 24 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 1.84 Information Ratio 0.91 Alpha Ratio 10.29 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 19 ₹10,000 30 Sep 20 ₹12,906 30 Sep 21 ₹24,645 30 Sep 22 ₹20,042 30 Sep 23 ₹24,031 30 Sep 24 ₹34,598 Returns for TATA Digital India Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Oct 24 Duration Returns 1 Month 0.9% 3 Month 13.3% 6 Month 21.9% 1 Year 42.9% 3 Year 11.7% 5 Year 28.6% 10 Year 15 Year Since launch 20.8% Historical performance (Yearly) on absolute basis
Year Returns 2023 31.9% 2022 -23.3% 2021 74.4% 2020 54.8% 2019 7.5% 2018 24.9% 2017 19.6% 2016 -6% 2015 2014 Fund Manager information for TATA Digital India Fund
Name Since Tenure Meeta Shetty 9 Mar 21 3.48 Yr. Kapil Malhotra 19 Dec 23 0.7 Yr. Data below for TATA Digital India Fund as on 31 Aug 24
Equity Sector Allocation
Sector Value Technology 78.92% Consumer Cyclical 6.69% Industrials 6.15% Communication Services 4.46% Financial Services 2.94% Asset Allocation
Asset Class Value Cash 0.84% Equity 99.16% Top Securities Holdings / Portfolio
Name Holding Value Quantity Infosys Ltd (Technology)
Equity, Since 31 Jan 16 | 50020921% ₹2,576 Cr 13,250,598 Tata Consultancy Services Ltd (Technology)
Equity, Since 31 Jan 16 | TCS11% ₹1,336 Cr 2,933,873 Tech Mahindra Ltd (Technology)
Equity, Since 30 Apr 16 | TECHM10% ₹1,169 Cr 7,145,933 HCL Technologies Ltd (Technology)
Equity, Since 31 Jan 16 | HCLTECH7% ₹874 Cr 4,983,886 LTIMindtree Ltd (Technology)
Equity, Since 28 Feb 21 | 5400056% ₹731 Cr 1,188,062 Zomato Ltd (Consumer Cyclical)
Equity, Since 31 Oct 22 | 5433206% ₹728 Cr 29,067,000 Wipro Ltd (Technology)
Equity, Since 31 Jul 18 | WIPRO5% ₹613 Cr 11,391,616
↑ 1,320,235 Persistent Systems Ltd (Technology)
Equity, Since 31 Jan 16 | PERSISTENT3% ₹393 Cr 759,192
↑ 10,000 Mphasis Ltd (Technology)
Equity, Since 30 Sep 20 | MPHASIS3% ₹331 Cr 1,065,817 Cyient Ltd (Industrials)
Equity, Since 28 Feb 21 | CYIENT3% ₹322 Cr 1,630,043
ਚੋਟੀ ਦੇ 5 ਹੌਟ ਮਿਉਚੁਅਲ ਫੰਡ 6 ਮਹੀਨੇ
ਹੇਠਾਂ ਸਭ ਤੋਂ ਵਧੀਆ ਮਿਉਚੁਅਲ ਫੰਡਾਂ ਦੀ ਸੂਚੀ ਦਿੱਤੀ ਗਈ ਹੈ ਜਿਨ੍ਹਾਂ ਦੀ ਕੁੱਲ ਜਾਇਦਾਦ ਵੱਧ ਹੈ100 ਕਰੋੜ ਅਤੇ ਪਿਛਲੇ 6 ਮਹੀਨਿਆਂ ਵਿੱਚ ਸਭ ਤੋਂ ਵਧੀਆ ਰਿਟਰਨ ਦਿੱਤਾ ਹੈ।
(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Midcap 30 Fund is a Equity - Mid Cap fund was launched on 24 Feb 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Midcap 30 Fund Returns up to 1 year are on The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Long Term Fund) The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Long Term Equity Fund is a Equity - ELSS fund was launched on 21 Jan 15. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Long Term Equity Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However
there can be no assurance that the investment objective under the Scheme will be realized. IDBI Small Cap Fund is a Equity - Small Cap fund was launched on 21 Jun 17. It is a fund with Moderately High risk and has given a Below is the key information for IDBI Small Cap Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on 1. Motilal Oswal Midcap 30 Fund
CAGR/Annualized return of 25.1% since its launch. Ranked 27 in Mid Cap category. Return for 2023 was 41.7% , 2022 was 10.7% and 2021 was 55.8% . Motilal Oswal Midcap 30 Fund
Growth Launch Date 24 Feb 14 NAV (11 Oct 24) ₹108.522 ↑ 0.74 (0.69 %) Net Assets (Cr) ₹15,940 on 31 Aug 24 Category Equity - Mid Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 0.66 Sharpe Ratio 2.94 Information Ratio 1.11 Alpha Ratio 15.07 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 19 ₹10,000 30 Sep 20 ₹9,728 30 Sep 21 ₹16,314 30 Sep 22 ₹20,069 30 Sep 23 ₹24,293 30 Sep 24 ₹41,736 Returns for Motilal Oswal Midcap 30 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Oct 24 Duration Returns 1 Month 3.9% 3 Month 12.3% 6 Month 33% 1 Year 70.6% 3 Year 35.5% 5 Year 34% 10 Year 15 Year Since launch 25.1% Historical performance (Yearly) on absolute basis
Year Returns 2023 41.7% 2022 10.7% 2021 55.8% 2020 9.3% 2019 9.7% 2018 -12.7% 2017 30.8% 2016 5.2% 2015 16.5% 2014 Fund Manager information for Motilal Oswal Midcap 30 Fund
Name Since Tenure Niket Shah 1 Jul 20 4.17 Yr. Rakesh Shetty 22 Nov 22 1.78 Yr. Sunil Sawant 1 Jul 24 0.17 Yr. Data below for Motilal Oswal Midcap 30 Fund as on 31 Aug 24
Equity Sector Allocation
Sector Value Industrials 23.28% Technology 20.63% Consumer Cyclical 17.61% Financial Services 6.64% Health Care 4.4% Basic Materials 4.29% Real Estate 1.43% Asset Allocation
Asset Class Value Cash 21.72% Equity 78.28% Top Securities Holdings / Portfolio
Name Holding Value Quantity Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | KALYANKJIL10% ₹1,538 Cr 25,000,000
↑ 5,750,000 Polycab India Ltd (Industrials)
Equity, Since 30 Sep 23 | POLYCAB9% ₹1,431 Cr 2,100,000 Persistent Systems Ltd (Technology)
Equity, Since 31 Jan 23 | PERSISTENT9% ₹1,403 Cr 2,713,800
↓ -36,200 Jio Financial Services Ltd (Financial Services)
Equity, Since 31 Aug 23 | 5439407% ₹1,058 Cr 32,900,000
↓ -600,000 Coforge Ltd (Technology)
Equity, Since 31 Mar 23 | COFORGE6% ₹1,015 Cr 1,600,000
↑ 100,000 Tube Investments of India Ltd Ordinary Shares (Industrials)
Equity, Since 31 Jul 20 | 5407626% ₹907 Cr 2,250,000
↑ 100,000 Voltas Ltd (Industrials)
Equity, Since 31 Oct 17 | 5005755% ₹872 Cr 5,000,000
↑ 2,000,000 Zomato Ltd (Consumer Cyclical)
Equity, Since 30 Apr 23 | 5433204% ₹639 Cr 25,500,000
↑ 500,000 Balkrishna Industries Ltd (Consumer Cyclical)
Equity, Since 28 Feb 23 | 5023554% ₹630 Cr 2,225,998
↓ -24,002 KPIT Technologies Ltd (Technology)
Equity, Since 31 Jan 23 | KPITTECH3% ₹545 Cr 3,000,000 2. LIC MF Infrastructure Fund
CAGR/Annualized return of 10.4% since its launch. Return for 2023 was 44.4% , 2022 was 7.9% and 2021 was 46.6% . LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (11 Oct 24) ₹52.0857 ↑ 0.19 (0.36 %) Net Assets (Cr) ₹725 on 31 Aug 24 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.3 Sharpe Ratio 3.65 Information Ratio 0.84 Alpha Ratio 26.87 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 19 ₹10,000 30 Sep 20 ₹8,670 30 Sep 21 ₹15,042 30 Sep 22 ₹16,606 30 Sep 23 ₹21,079 30 Sep 24 ₹36,513 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Oct 24 Duration Returns 1 Month 1.7% 3 Month -0.8% 6 Month 31.6% 1 Year 71.4% 3 Year 33.3% 5 Year 30.2% 10 Year 15 Year Since launch 10.4% Historical performance (Yearly) on absolute basis
Year Returns 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% 2014 49.6% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 3.96 Yr. Mahesh Bendre 1 Jul 24 0.17 Yr. Data below for LIC MF Infrastructure Fund as on 31 Aug 24
Equity Sector Allocation
Sector Value Industrials 54.07% Basic Materials 10.78% Consumer Cyclical 7.82% Utility 6.16% Financial Services 5.91% Technology 2.75% Health Care 2.23% Communication Services 2.1% Real Estate 1.77% Energy 1.18% Asset Allocation
Asset Class Value Cash 5.23% Equity 94.77% Top Securities Holdings / Portfolio
Name Holding Value Quantity Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | SCHNEIDER4% ₹27 Cr 324,490 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006554% ₹26 Cr 78,425
↑ 3,834 Cummins India Ltd (Industrials)
Equity, Since 31 May 21 | CUMMINSIND3% ₹25 Cr 65,432
↑ 17,704 Bharat Bijlee Ltd (Industrials)
Equity, Since 31 Jul 22 | BBL3% ₹24 Cr 44,119 Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP3% ₹22 Cr 50,196
↑ 6,320 ISGEC Heavy Engineering Ltd (Industrials)
Equity, Since 31 Jul 24 | 5330333% ₹20 Cr 143,752
↑ 46,366 DEE Development Engineers Ltd (Industrials)
Equity, Since 30 Jun 24 | DEEDEV2% ₹18 Cr 510,671
↑ 173,823 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | RECLTD2% ₹18 Cr 282,878
↑ 95,059 GE T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | GET&D2% ₹16 Cr 95,179 Yatharth Hospital and Trauma Care Services Ltd (Healthcare)
Equity, Since 30 Jun 24 | 5439502% ₹16 Cr 309,230 3. Motilal Oswal Long Term Equity Fund
CAGR/Annualized return of 19.3% since its launch. Return for 2023 was 37% , 2022 was 1.8% and 2021 was 32.1% . Motilal Oswal Long Term Equity Fund
Growth Launch Date 21 Jan 15 NAV (11 Oct 24) ₹55.4597 ↑ 0.29 (0.52 %) Net Assets (Cr) ₹3,984 on 31 Aug 24 Category Equity - ELSS AMC Motilal Oswal Asset Management Co. Ltd Rating Risk Moderately High Expense Ratio 0.74 Sharpe Ratio 3.66 Information Ratio 0.88 Alpha Ratio 15.26 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 30 Sep 19 ₹10,000 30 Sep 20 ₹9,154 30 Sep 21 ₹15,242 30 Sep 22 ₹14,688 30 Sep 23 ₹18,482 30 Sep 24 ₹30,785 Returns for Motilal Oswal Long Term Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Oct 24 Duration Returns 1 Month 4.7% 3 Month 13.1% 6 Month 29.2% 1 Year 67.8% 3 Year 26.7% 5 Year 26.2% 10 Year 15 Year Since launch 19.3% Historical performance (Yearly) on absolute basis
Year Returns 2023 37% 2022 1.8% 2021 32.1% 2020 8.8% 2019 13.2% 2018 -8.7% 2017 44% 2016 12.5% 2015 2014 Fund Manager information for Motilal Oswal Long Term Equity Fund
Name Since Tenure Ajay Khandelwal 11 Dec 23 0.73 Yr. Niket Shah 17 Oct 23 0.88 Yr. Rakesh Shetty 22 Nov 22 1.78 Yr. Data below for Motilal Oswal Long Term Equity Fund as on 31 Aug 24
Equity Sector Allocation
Sector Value Industrials 34.17% Consumer Cyclical 26.15% Financial Services 16.54% Real Estate 8.24% Health Care 5.63% Technology 2.68% Basic Materials 2.46% Asset Allocation
Asset Class Value Cash 4.13% Equity 95.87% Top Securities Holdings / Portfolio
Name Holding Value Quantity Trent Ltd (Consumer Cyclical)
Equity, Since 31 Aug 22 | TRENT8% ₹315 Cr 439,590 Zomato Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | 5433208% ₹314 Cr 12,550,000 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | KALYANKJIL5% ₹203 Cr 3,296,932 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 31 Oct 23 | PRESTIGE5% ₹191 Cr 1,055,205 Suzlon Energy Ltd (Industrials)
Equity, Since 31 Jan 24 | 5326675% ₹183 Cr 24,068,813 Inox Wind Ltd (Industrials)
Equity, Since 31 Dec 23 | INOXWIND4% ₹176 Cr 7,946,960 Kaynes Technology India Ltd (Industrials)
Equity, Since 30 Jun 23 | 5436644% ₹142 Cr 298,614 Phoenix Mills Ltd (Real Estate)
Equity, Since 29 Feb 24 | PHOENIXLTD3% ₹137 Cr 363,473 Apar Industries Ltd (Industrials)
Equity, Since 31 Dec 23 | APARINDS3% ₹136 Cr 148,305 CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 30 Nov 23 | 5000933% ₹131 Cr 1,875,000 4. IDBI Small Cap Fund
CAGR/Annualized return of 18.1% since its launch. Return for 2023 was 33.4% , 2022 was 2.4% and 2021 was 64.7% . IDBI Small Cap Fund
Growth Launch Date 21 Jun 17 NAV (11 Oct 24) ₹33.8251 ↑ 0.26 (0.78 %) Net Assets (Cr) ₹348 on 31 Aug 24 Category Equity - Small Cap AMC IDBI Asset Management Limited Rating Risk Moderately High Expense Ratio 2.3 Sharpe Ratio 2.56 Information Ratio 0.12 Alpha Ratio 9.09 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 19 ₹10,000 30 Sep 20 ₹10,100 30 Sep 21 ₹18,280 30 Sep 22 ₹20,588 30 Sep 23 ₹24,418 30 Sep 24 ₹37,706 Returns for IDBI Small Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Oct 24 Duration Returns 1 Month 0.7% 3 Month 3.8% 6 Month 28.7% 1 Year 51.8% 3 Year 25.3% 5 Year 31.2% 10 Year 15 Year Since launch 18.1% Historical performance (Yearly) on absolute basis
Year Returns 2023 33.4% 2022 2.4% 2021 64.7% 2020 19% 2019 -4.4% 2018 -15% 2017 2016 2015 2014 Fund Manager information for IDBI Small Cap Fund
Name Since Tenure Nikhil Rungta 1 Jul 24 0.17 Yr. Mahesh Bendre 1 Jul 24 0.17 Yr. Data below for IDBI Small Cap Fund as on 31 Aug 24
Equity Sector Allocation
Sector Value Industrials 41.51% Basic Materials 12.52% Consumer Cyclical 11.29% Health Care 6.45% Consumer Defensive 6% Utility 5.51% Technology 5.11% Financial Services 3.1% Communication Services 2.1% Real Estate 1.29% Energy 0.89% Asset Allocation
Asset Class Value Cash 3.76% Equity 96.24% Top Securities Holdings / Portfolio
Name Holding Value Quantity JTL Industries Ltd (Basic Materials)
Equity, Since 31 Jul 24 | 5346003% ₹12 Cr 486,149
↑ 59,609 Kirloskar Oil Engines Ltd (Industrials)
Equity, Since 28 Feb 21 | KIRLOSENG3% ₹12 Cr 86,263 Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP3% ₹11 Cr 25,190
↓ -5,108 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006553% ₹11 Cr 33,577
↓ -6,574 Bharat Bijlee Ltd (Industrials)
Equity, Since 31 Aug 23 | BBL3% ₹9 Cr 17,360 KSB Ltd (Industrials)
Equity, Since 31 Mar 21 | 5002492% ₹9 Cr 93,570
↑ 16,753 Kennametal India Ltd (Industrials)
Equity, Since 31 Aug 23 | 5058902% ₹8 Cr 26,305 KEI Industries Ltd (Industrials)
Equity, Since 31 Dec 17 | 5175692% ₹8 Cr 17,539 Arvind Fashions Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | ARVINDFASN2% ₹8 Cr 151,805 Texmaco Rail & Engineering Ltd (Industrials)
Equity, Since 30 Nov 23 | 5333262% ₹8 Cr 331,875 5. UTI Healthcare Fund
CAGR/Annualized return of 15.5% since its launch. Ranked 40 in Sectoral category. Return for 2023 was 38.2% , 2022 was -12.3% and 2021 was 19.1% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (11 Oct 24) ₹289.796 ↑ 0.83 (0.29 %) Net Assets (Cr) ₹1,168 on 31 Aug 24 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 2.49 Information Ratio -0.01 Alpha Ratio 1.29 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 19 ₹10,000 30 Sep 20 ₹16,648 30 Sep 21 ₹21,858 30 Sep 22 ₹19,247 30 Sep 23 ₹23,816 30 Sep 24 ₹37,158 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 11 Oct 24 Duration Returns 1 Month 0.8% 3 Month 17.5% 6 Month 28.7% 1 Year 57.7% 3 Year 19.2% 5 Year 30.6% 10 Year 15 Year Since launch 15.5% Historical performance (Yearly) on absolute basis
Year Returns 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% 2014 43.7% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 2.34 Yr. Data below for UTI Healthcare Fund as on 31 Aug 24
Equity Sector Allocation
Sector Value Health Care 95.09% Financial Services 1.33% Basic Materials 1.06% Asset Allocation
Asset Class Value Cash 2.41% Equity 97.48% Debt 0.11% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA11% ₹134 Cr 735,274 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000877% ₹78 Cr 469,180 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | AJANTPHARM6% ₹65 Cr 200,000
↓ -35,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY5% ₹61 Cr 87,100 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP4% ₹45 Cr 64,796 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | GLENMARK4% ₹43 Cr 250,331 Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | ERIS4% ₹41 Cr 297,746 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMA3% ₹39 Cr 250,000
↓ -5,167 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5001263% ₹39 Cr 74,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5328433% ₹35 Cr 634,445
ਮਿਉਚੁਅਲ ਫੰਡਾਂ ਵਿੱਚ ਔਨਲਾਈਨ ਨਿਵੇਸ਼ ਕਿਵੇਂ ਕਰੀਏ?
Fincash.com 'ਤੇ ਜੀਵਨ ਭਰ ਲਈ ਮੁਫਤ ਨਿਵੇਸ਼ ਖਾਤਾ ਖੋਲ੍ਹੋ।
ਆਪਣੀ ਰਜਿਸਟ੍ਰੇਸ਼ਨ ਅਤੇ ਕੇਵਾਈਸੀ ਪ੍ਰਕਿਰਿਆ ਨੂੰ ਪੂਰਾ ਕਰੋ
ਦਸਤਾਵੇਜ਼ (ਪੈਨ, ਆਧਾਰ, ਆਦਿ) ਅੱਪਲੋਡ ਕਰੋ।ਅਤੇ, ਤੁਸੀਂ ਨਿਵੇਸ਼ ਕਰਨ ਲਈ ਤਿਆਰ ਹੋ!
ਇਹ ਯਕੀਨੀ ਬਣਾਉਣ ਲਈ ਸਾਰੇ ਯਤਨ ਕੀਤੇ ਗਏ ਹਨ ਕਿ ਇੱਥੇ ਦਿੱਤੀ ਗਈ ਜਾਣਕਾਰੀ ਸਹੀ ਹੈ। ਹਾਲਾਂਕਿ, ਡੇਟਾ ਦੀ ਸ਼ੁੱਧਤਾ ਬਾਰੇ ਕੋਈ ਗਾਰੰਟੀ ਨਹੀਂ ਦਿੱਤੀ ਗਈ ਹੈ। ਕਿਰਪਾ ਕਰਕੇ ਕੋਈ ਵੀ ਨਿਵੇਸ਼ ਕਰਨ ਤੋਂ ਪਹਿਲਾਂ ਸਕੀਮ ਜਾਣਕਾਰੀ ਦਸਤਾਵੇਜ਼ ਨਾਲ ਤਸਦੀਕ ਕਰੋ।
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2024 Shepard Technologies Private Limited. All Rights Reserved